Bharat Immunological & Biological Corporation (BIBC) Hits 52-Week Low Amidst Poor Performance

Nov 14 2024 11:35 AM IST
share
Share Via
Bharat Immunological & Biological Corporation (BIBC) has been struggling in the market, with its stock hitting a 52-week low and falling by -10.28% in the last 5 days. According to MarketsMojo, the stock call for BIBC is currently 'Strong Sell' due to its poor performance and downward trend in stock price. BIBC has also underperformed in comparison to the overall market, with a -4.50% return in the past year. As a microcap pharmaceutical company, BIBC may face challenges in competing with larger players in the industry. However, investors should conduct their own research before making any investment decisions.

Bharat Immunological & Biological Corporation (BIBC) has recently hit a 52-week low on November 14, 2024, with its stock price dropping to Rs.22.25. This microcap pharmaceutical company has been underperforming in the market, with its stock falling by -10.28% in the last 5 days alone.

According to MarketsMOJO, a leading stock analysis and recommendation platform, the stock call for BIBC is currently 'Strong Sell'. This is due to the company's poor performance and consecutive fall in stock price.

BIBC's stock is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in its stock price.

In comparison to the overall market performance, BIBC has not fared well in the past year, with a -4.50% return, while the Sensex has seen a 19.33% growth.

As a microcap company in the pharmaceutical industry, BIBC may face challenges in competing with larger players in the market. However, it is important to note that this information is based on past performance and does not reflect the potential of the company in the future. Investors should conduct their own research and analysis before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Bharat Immunolog falling/rising?
Dec 23 2025 01:49 AM IST
share
Share Via
Why is Bharat Immunolog falling/rising?
Oct 31 2025 10:41 PM IST
share
Share Via
Why is Bharat Immunolog falling/rising?
Sep 24 2025 10:23 PM IST
share
Share Via
Why is Bharat Immunolog falling/rising?
Sep 23 2025 10:34 PM IST
share
Share Via